PROGNOSIS OF SHORT-TERM (3-MONTH) VERSUS STANDARD (12-MONTH) DUAL ANTI-PLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Optimal duration of DAPT in patients with ACS who were treated with drug eluting stents is a challenging topic. Recent studies reported no significant difference in mortality and thrombotic events between 6-month vs 12-month DAPT. Subgroup analysis comparing 3-month vs 12-month DAPT was not